Perimenopause depression: the window of vulnerability

A real and measurable rise in risk

This is not a soft claim. Longitudinal studies following the same women through the transition consistently find a higher rate of depressive symptoms and of diagnosed depressive episodes during perimenopause than before it, with estimates commonly around a doubling of risk.

The elevation is concentrated in perimenopause rather than after menopause, which again points at fluctuation rather than deficiency as the driver.

Risk is not evenly spread. It is markedly higher in women with a previous depressive episode, a history of postnatal depression, or severe premenstrual mood symptoms — three conditions that share an estrogen-withdrawal signature. If any of those apply, this is worth knowing in advance rather than discovering.

Why it is so often missed

Perimenopausal depression frequently does not look like the textbook picture. Sadness and tearfulness may be minor features. What dominates is often irritability, anger disproportionate to its trigger, a flattened inability to feel pleasure, loss of confidence and self-worth, and a pervasive sense of not being oneself.

Because the presentation skews towards irritability, it gets read as stress, as a difficult phase, or as a personality change, by the person experiencing it as much as by those around her.

The context also disguises it. The transition typically lands in the years of teenagers, ageing parents and career peak, and there is always an external explanation available to prefer.

Why the distinction changes treatment

For depression generally, hormone therapy is not a treatment. For low mood arising during perimenopause, guidance is different: NICE explicitly states that hormone therapy should be considered for low mood arising as part of the menopause, and that antidepressants should not be offered first-line for low mood in menopausal women who have not been diagnosed with depression.

That is an important and frequently unapplied distinction. It does not mean antidepressants are wrong here — they are appropriate and effective for many people, and essential where there is diagnosed depression. It means the sequence should be a deliberate decision rather than a default.

Psychological therapy has good evidence throughout and is not in competition with either.

What else to check

Thyroid dysfunction, iron deficiency and vitamin D deficiency all produce low mood and fatigue, are common in this age group, and are simple tests. Untreated sleep apnoea presents with depression in women more often than the classic picture suggests.

Alcohol use frequently rises quietly in this phase and is both a depressant and a sleep disruptor. It is worth counting honestly before concluding nothing is helping.

When to see someone

Low mood persisting more than two weeks, or any loss of interest in things that previously mattered, deserves an appointment. Bring the timeline and the cycle history, because both are what distinguish this from depression arising independently.

Get help immediately for thoughts of suicide or self-harm. Rates of suicide in women peak in the perimenopausal age range, and this symptom is never something to wait out.